Pro Share Advisors LLC Veracyte, Inc. Transaction History

Pro Share Advisors LLC

  • $46.4 Billion
  • Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,575 shares of VCYT stock, worth $691,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,575
Previous 18,997 7.49%
Holding current value
$691,576
Previous $513,000 17.54%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025
SELL
$23.03 - $34.33 $32,748 - $48,817
-1,422 Reduced 7.49%
17,575 $603,000
Q2 2025

Aug 07, 2025
SELL
$26.39 - $32.62 $36,523 - $45,146
-1,384 Reduced 6.79%
18,997 $513,000
Q1 2025

May 08, 2025
SELL
$29.65 - $46.14 $146,174 - $227,470
-4,930 Reduced 19.48%
20,381 $604,000
Q4 2024

Feb 13, 2025
BUY
$31.92 - $44.4 $199,531 - $277,544
6,251 Added 32.8%
25,311 $1 Million
Q3 2024

Nov 13, 2024
BUY
$21.0 - $35.25 $96,390 - $161,797
4,590 Added 31.72%
19,060 $648,000
Q2 2024

Aug 13, 2024
SELL
$18.86 - $23.55 $73,025 - $91,185
-3,872 Reduced 21.11%
14,470 $313,000
Q1 2024

May 08, 2024
BUY
$21.0 - $29.1 $34,125 - $47,287
1,625 Added 9.72%
18,342 $406,000
Q4 2023

Feb 14, 2024
BUY
$19.72 - $28.68 $49,398 - $71,843
2,505 Added 17.63%
16,717 $459,000
Q3 2023

Nov 13, 2023
BUY
$22.33 - $29.92 $1,295 - $1,735
58 Added 0.41%
14,212 $317,000
Q2 2023

Aug 10, 2023
SELL
$20.96 - $26.99 $1,027 - $1,322
-49 Reduced 0.34%
14,154 $360,000
Q1 2023

May 11, 2023
SELL
$20.58 - $27.89 $19,592 - $26,551
-952 Reduced 6.28%
14,203 $316,000
Q4 2022

Feb 02, 2023
BUY
$15.31 - $29.94 $18,892 - $36,945
1,234 Added 8.86%
15,155 $359,000
Q3 2022

Nov 04, 2022
BUY
$16.58 - $27.9 $5,090 - $8,565
307 Added 2.26%
13,921 $231,000
Q2 2022

Aug 01, 2022
SELL
$15.45 - $29.52 $98,988 - $189,134
-6,407 Reduced 32.0%
13,614 $270,000
Q1 2022

May 10, 2022
SELL
$21.94 - $42.51 $103,337 - $200,222
-4,710 Reduced 19.04%
20,021 $552,000
Q4 2021

Feb 08, 2022
BUY
$36.09 - $53.79 $34,105 - $50,831
945 Added 3.97%
24,731 $1.02 Million
Q3 2021

Nov 12, 2021
SELL
$35.62 - $52.97 $206,667 - $307,331
-5,802 Reduced 19.61%
23,786 $1.11 Million
Q2 2021

Aug 13, 2021
BUY
$32.94 - $56.62 $86,072 - $147,948
2,613 Added 9.69%
29,588 $1.18 Million
Q1 2021

May 14, 2021
BUY
$44.47 - $81.38 $237,914 - $435,383
5,350 Added 24.74%
26,975 $1.45 Million
Q4 2020

Feb 09, 2021
BUY
$32.49 - $61.88 $178,207 - $339,411
5,485 Added 33.98%
21,625 $1.06 Million
Q3 2020

Nov 13, 2020
BUY
$26.73 - $35.67 $36,005 - $48,047
1,347 Added 9.11%
16,140 $524,000
Q2 2020

Aug 03, 2020
BUY
$19.49 - $28.11 $103,433 - $149,179
5,307 Added 55.95%
14,793 $383,000
Q1 2020

May 15, 2020
SELL
$16.13 - $30.17 $120,507 - $225,400
-7,471 Reduced 44.06%
9,486 $231,000
Q4 2019

Feb 12, 2020
SELL
$20.78 - $29.99 $31,855 - $45,974
-1,533 Reduced 8.29%
16,957 $473,000
Q3 2019

Nov 12, 2019
BUY
$23.87 - $30.93 $41,438 - $53,694
1,736 Added 10.36%
18,490 $444,000
Q2 2019

Aug 13, 2019
SELL
$22.1 - $28.56 $6,320 - $8,168
-286 Reduced 1.68%
16,754 $478,000
Q1 2019

May 15, 2019
BUY
$12.0 - $25.76 $3,492 - $7,496
291 Added 1.74%
17,040 $426,000
Q4 2018

Feb 14, 2019
SELL
$9.15 - $14.85 $25,592 - $41,535
-2,797 Reduced 14.31%
16,749 $211,000
Q3 2018

Nov 14, 2018
BUY
$9.55 - $12.64 $18,402 - $24,357
1,927 Added 10.94%
19,546 $187,000
Q2 2018

Aug 13, 2018
SELL
$5.39 - $9.66 $6,812 - $12,210
-1,264 Reduced 6.69%
17,619 $165,000
Q1 2018

May 14, 2018
SELL
$5.44 - $6.97 $16,162 - $20,707
-2,971 Reduced 13.59%
18,883 $105,000
Q4 2017

Feb 14, 2018
BUY
$6.05 - $9.37 $132,216 - $204,771
21,854
21,854 $143,000

Others Institutions Holding VCYT

# of Institutions
324
Shares Held
78.9M
Call Options Held
94.6K
Put Options Held
6.7K
View Full List

About VERACYTE, INC.

VCYT Quotes by TradingView
  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.82B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email